Brief: Centessa Pharmaceuticals Announces Non-Human Primate Pharmacokinetic And Safety Data For LB101 (PD-L1xcd47) Demonstrating Potential For Enhanced Therapeutic Index

Centessa Pharmaceuticals

12/09/2022 12:05

Sept 12 (Reuters) - Centessa Pharmaceuticals PLC  260y.F :
    * CENTESSA PHARMACEUTICALS ANNOUNCES NON-HUMAN PRIMATE
PHARMACOKINETIC AND SAFETY DATA FOR LB101 (PD-L1XCD47)
DEMONSTRATING POTENTIAL FOR ENHANCED THERAPEUTIC INDEX
    * CENTESSA PHARMA - THERE WERE NO ADVERSE CHANGES IN
HEMATOLOGIC
PARAMETERS, NO CHANGES IN BODY WEIGHTS AND NO ADVERSE TOXICOLOGY
FINDINGS IN STUDY

Source text for Eikon:  ID:nGNX4TDg2L 
Further company coverage:  260y.F 

 ((Reuters.Briefs@thomsonreuters.com;))